SambaNova Raises $1B at $11B Valuation Months After Intel Talks Collapsed

TL;DR: SambaNova Systems just closed the first tranche of a Series F round: $1 billion at an $11 billion valuation, led by General Atlantic, with a second close still pending more investors as of July 8, 2026. That's roughly 2.3x the company's Series E valuation from five months earlier and nearly 7x the $1.6 billion price Intel reportedly offered to acquire the whole company back in December 2025. If you're an accredited investor looking at SPV (special purpose vehicle) or secondaries access to this round, you need to understand why the number moved that fast, and what it says about how AI infrastructure deals get priced right now.

According to TechCrunch, SambaNova raised $1 billion in the first close of its Series F at an $11 billion valuation, just five months after closing a $350 million Series E. General Atlantic led the new round. That headline alone should stop you before you chase an allocation through a feeder fund or secondary marketplace: a company that was reportedly close to selling itself for $1.6 billion seven months ago is now being marked at nearly 7x that figure, with no IPO, no audited public financials, and (by outside estimates) revenue that doesn't yet clear $50 million in annual recurring revenue. I've covered a lot of late-stage AI rounds this cycle. This is one of the more dramatic valuation swings I've seen from a single private company in under a year.

What SambaNova Actually Sells, and Who's Buying In

SambaNova Systems, co-founded by CEO Rodrigo Liang and Stanford professor Kunle Olukotun, builds custom AI chips and systems designed to compete with Nvidia's GPUs for running and training large language models. Its flagship silicon, the SN50 RDU (Reconfigurable Dataflow Unit), is pitched as faster and more power-efficient for "agentic AI" workloads: software that doesn't just answer a prompt but chains together multiple reasoning and action steps on its own. SambaNova has marketed this angle heavily, including in a press release announcing what it called its fastest chip for agentic AI alongside a collaboration with Intel and the $350 million-plus Series E raise in February 2026.

That Series E, according to data compiled by Tracxn, was led by Vista Equity Partners and Cambium Capital and implied a valuation in the $4.8 billion to $5 billion range. The new Series F first close puts the company at $11 billion, more than double that mark. The investor roster tells you who's willing to underwrite this jump: past and reported backers include Intel Capital, T. Rowe Price Associates, BlackRock, the Qatar Investment Authority, Capital Group, Battery Ventures, Seligman Ventures, and SoftBank, which led SambaNova's $676 million Series D at a $5 billion valuation back in April 2021. Total funding raised across all rounds since the company's 2018 founding sits somewhere between $1.48 billion and $1.83 billion, depending on how you count debt-linked instruments, per Tracxn and CB Insights data.

This is not a retail-accessible stock. It's a private company financed almost entirely by institutional capital, sovereign wealth, and late-stage growth funds. When SambaNova exposure trickles down to accredited individual investors, it typically arrives through an SPV, a fund-of-one wrapper that pools smaller checks into a single line on a cap table, or through a secondaries transaction where an early employee or fund LP sells existing shares at a negotiated price. Both structures charge carry and fees on top of whatever the underlying valuation is doing. If you want to understand how those wrappers are typically structured and priced, our explainer on SPV investing mechanics and fee structures walks through the math.

The Intel Deal That Almost Happened

Here's the part of the timeline that should give you pause. According to Bloomberg Law, Intel was near a deal to acquire SambaNova for approximately $1.6 billion, including assumed debt, with a term sheet reportedly signed in December 2025. Intel CEO Lip-Bu Tan has been under pressure to consolidate Intel's AI hardware strategy since taking the role, and folding in SambaNova's dataflow architecture and engineering team looked like a plausible path. Then the talks collapsed. By January 2026, the acquisition was dead, and SambaNova stayed independent.

Seven months later, the company that a strategic acquirer valued at $1.6 billion is raising fresh venture capital at $11 billion. That's not a modest re-rating. That's a near-7x swing on the same underlying assets, the same engineering team, and, as far as public disclosures show, no transformative new revenue base to justify it. Independent analysis circulating among AI infrastructure watchers, including estimates referenced by industry researchers, puts SambaNova's annual recurring revenue at under $50 million as of mid-2025, against annual cash burn reportedly exceeding $200 million. Those figures aren't company-disclosed and I can't verify them against an audited filing because none exists for a private company at this stage. But if they're even directionally right, you have a business burning four times what it earns in revenue, priced at 220x that revenue figure.

Compare that arithmetic to how public markets treat comparable AI infrastructure names. Even the most richly valued public AI hardware companies trade on some multiple of actual disclosed revenue, reviewed quarterly by auditors and subject to SEC enforcement if the numbers are wrong. SambaNova's valuation is being set in a negotiation between the company and a handful of large investors who each have their own reasons for wanting exposure to the AI infrastructure theme, whether or not the per-share price reflects fundamentals a public-market analyst would accept.

Why This Pattern Matters Beyond One Company

SambaNova isn't unique. Its two closest direct competitors in the AI chip space, Cerebras Systems and Groq, have run through similarly compressed and volatile private funding cycles: big valuation jumps on each new round, heavy reliance on a small set of overlapping late-stage investors, and, in Cerebras's case, a long and ultimately abandoned path toward a public listing. If you're evaluating a SPV or fund pitch built around any of these three companies, or the next one that follows the same playbook, the SambaNova timeline is a useful stress test. Ask the sponsor raising your SPV: what was the last actual acquisition offer for this company, when did it happen, and how does that number compare to what I'm being asked to pay today?

I'd also point you to how Reuters and other outlets have covered the broader AI infrastructure financing wave this cycle: repeated rounds within months of each other, each one priced up sharply, with investor syndicates that increasingly overlap. When the same 15 to 20 growth funds and sovereign wealth vehicles are writing checks into every marquee AI infrastructure name, the "market price" for any one of them starts to reflect what that specific pool of capital is willing to pay to stay in the game, not necessarily an independent read on enterprise value. That's not fraud. It's momentum pricing, and momentum reverses. It reversed hard enough that Intel walked away from a $1.6 billion deal seven months before the same asset was marked at $11 billion by a different set of buyers.

For context on how quickly late-stage AI valuations can also move in the other direction, look at how some 2021-vintage AI and software unicorns were repriced down 60% to 90% in 2022 and 2023 down rounds once public comparables reset and cheap capital dried up. SambaNova itself lived through a version of that: its Series D valued it at $5 billion in April 2021, and by the time Intel was circling in late 2025, the implied price on the table was less than a third of that figure. The current $11 billion mark could hold, could keep climbing if a second Series F close brings in even richer pricing, or could look just as exposed the next time the credit or AI-capex cycle turns. Nobody, including me, knows which outcome wins. That uncertainty is the actual product you're buying when you buy into a round like this.

What Accredited Investors Should Actually Check

If you're weighing a SambaNova SPV, secondary share purchase, or exposure through a venture fund that holds a position, run through this before you wire money:

• Ask for the actual share class and preference stack. Late-stage rounds often carry liquidation preferences that protect the newest money first. A common share purchased on the secondary market may not carry the same downside protection as the preferred stock in the headline round.
• Ask what "$11 billion valuation" actually means in the deal documents: is it a pre-money or post-money figure, and does it include the new $1 billion raised or value the company before that capital came in?
• Ask the sponsor for their basis: what price per share are you actually paying, and how does that compare to the price General Atlantic and other Series F investors are paying in the same round?
• Confirm there's no public SEC Form D or comparable filing you should be cross-referencing. Private placements over certain thresholds require a Form D filing with the SEC, which won't give you financials but will confirm the raise actually happened and who the exempt offering was sold through.
• Understand your liquidity horizon. There's no indication SambaNova is filing for an IPO. Your capital could be locked up for five, seven, or more years with no secondary market guarantee.

None of this means don't invest. It means don't invest on the headline number alone. A $1 billion raise at an $11 billion valuation, led by a credible growth investor like General Atlantic, is a real data point. It is not, by itself, evidence that the business is worth $11 billion in any sense a public market would recognize. If you want a broader framework for how secondaries pricing typically diverges from headline primary-round valuations, our piece on secondaries platforms and private share pricing is a good next stop, as is our breakdown of Series C and late-stage funding round structures if you want the mechanics of how these preference stacks typically get built.

Frequently Asked Questions

Is SambaNova's $11 billion valuation confirmed by a public filing?
No. The $11 billion figure comes from reporting on the first close of the Series F round, cited by TechCrunch and sourced to people familiar with the deal. Private valuations at this stage are negotiated between the company and investors and generally aren't required to be disclosed publicly unless triggered by a Form D filing with the SEC, which discloses that an exempt offering occurred but not the underlying financials or valuation logic.

Why would Intel walk away from a $1.6 billion acquisition and then watch the same company raise money at $11 billion months later?
The two events reflect different buyers with different motives. An acquirer like Intel is typically pricing based on integration value, existing revenue, and strategic overlap, discounted by the risk and cost of a full acquisition and integration. Growth investors in a minority-stake financing round are pricing based on market momentum, competitive positioning against Nvidia, Cerebras, and Groq, and a bet on the AI infrastructure buildout continuing. Both prices can be "correct" for the buyer making them; they aren't measuring the same thing.

How can an accredited investor actually get exposure to a private company like SambaNova?
The two most common paths are an SPV, where a sponsor pools capital from multiple accredited investors into a single vehicle that buys a stake in the round or from an existing shareholder, and a secondaries transaction, where you buy shares directly from an early employee, founder, or fund LP who wants liquidity before an IPO or acquisition. Both require you to qualify as an accredited investor under SEC rules, and both typically carry sponsor fees and carried interest on top of the underlying share price.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.